Abstract BBS8 is one of the eight genes identified to date for Bardet-Biedl syndrome (BBS)-an autosomal recessive condition associated with retinitis pigmentosa, obesity, polydactyly, cognitive impairment and kidney failure. The identification of BBS8 gave the key to the pathogenesis of the condition as a primary ciliary disorder. To date, only three families mutated in the BBS8 gene have been reported. Here, we report on three additional families with BBS8 mutations from a series of 128 BBS families. Two of the three families have homozygous mutations and one has a heterozygous mutation. Mutations in BBS8 probably account for only a minority of BBS families (2%), underlining the difficulty of genotyping heterogeneous conditions.
Introduction
Bardet-Biedl syndrome (BBS) is a genetically heterogeneous condition characterised by early-onset retinitis pigmentosa, obesity, polydactyly, hypogonadism, learning disabilities, and kidney malformation. A tremendous amount of knowledge about BBS has recently accumulated, demonstrating extensive genetic heterogeneity and giving clues as to the ciliary pathogenesis of this complex condition. It has also been suggested that its inheritance may depart from the classic autosomal recessive mode, and may involve, in some families, three mutated alleles in two genes (triallelic inheritance) (Katsanis et al. 2001) .
To date, eight BBS genes have been identified: BBS1 (11q13; Mykytyn et al. 2002) , BBS2 (16q21; Nishimura et al. 2001); BBS3 (3p13-p12; Fan et al. 2004; Chiang et al. 2004), BBS4 (15q22.3-q23; Mykytyn et al. 2001) ; BBS5 (2q31; Li et al. 2004); BBS6 (20 p12; Slaovotinek et al. 2000; Katsanis et al. 2000) , BBS7 (4q27; Badano et al. 2003) and BBS8 (14q32.11; Ansley et al. 2003) .
The identification of BBS8, encoding a centrosomal and basal body protein, designated BBS as a primary cilia disorder . Since then, functional overlap between BBS genes at the level of basal body and cilia is now well recognized and various bbs transgenic mice have been reported.
BBS8 maps to the 14q32.11 region and spans 15 exons. The BBS8 protein (TTC8), like BBS4, contains several tetratricopeptide repeats (TPRs) involved in protein-protein interactions. This protein is associated with centriolar structures and interacts with PCM-1, which is involved with basal body function .
To date, mutations in BBS8 have been reported only for three families : two families of Saudi Arabian lineage have a homozygous in-frame deletion of 6 bp in exon 6, and one family of Pakistani descent was reported to have a 3-bp deletion at the splice site junction of exon 10. Herein, we report BBS8 mutations in three BBS families out of a cohort of 128 BBS families.
Materials and methods

Families
This study was performed on a series of 128 families containing one or more patients with a diagnosis of BBS (Beales et al. 1999 ).
Methods
Mutation screening in BBS8 was performed by DHPLC analysis using at least three melting temperatures for each amplicon, followed by direct sequencing of the variant PCR fragments as described previously (Hichri et al. 2005) . Splice site scoring programs (http://l25. itba.mi.cnr.it/$webgene/wwwspliceview.html, http://www. fruitfly.org/seq_tools/splice.html) were used to evaluate the effect of mutations affecting splice sites and to detect potential consequences on splicing of silent, or missense changes and intronic variations. ESE web servers (http://genes.mit.edu/burgelab/rescue-ese, http://rulia.cshl.edu/tools/ESE) were used to search for potential exonic splicing enhancers in exonic variants (silent or missense mutations).
Results
Three families with BBS8 mutations were identified, of which two showed homozygous mutations and one showed a heterozygous mutation.
Family one is a consanguineous family of NorthAfrican descent with three BBS affected sibs and three non-affected sibs (Fig. 1) . Affected sibs harboured a homozygous splice-site mutation (T153T, 459G>A) affecting the last G of exon 4 of BBS8 and predicted to abolish the splice site of exon 4. Screening for other BBS genes for this family revealed an additional BBS7 mutation (M114 V, 340A>G) for one sib only (Figs. 1,  2 ). This mutation is predicted to affect the donor splice site of exon 4 of BBS7. No clinical difference was recorded for the three BBS sibs and no cell-line is available.
Family two is a sporadic case of Lebanese lineage. The proband, born from a consanguineous marriage, showed a homozygous splice site mutation (IVS6 + 1-G>A) at the level of exon 6 of BBS8 (the DNA of other members of the family is not available) (Fig. 2) . No other mutation in any known BBS gene has been identified to date. for a hydrometrocolpos and had polydactyly at the level of the hands and feet. She developed retinitis pigmentosa and progressive renal failure. Patient II.6 was born with polydactyly at the level of the hands and feet, retinitis pigmentosa and kidney dysplasia Family three, a sporadic case born from caucasian non-consanguineous parents carried a heterozygous mutation in the donor splice site of exon 6 of BBS8 (IVS6+1À2delGT) (Fig. 2) .
Two exonic variations were identified during this study. The R79R change, which creates a weak exonic splicing enhancer (ESE), found in one patient was not found in 137 matched controls. The K85R change found in three patients and in one control out of 137 matched controls is predicted to abolish two ESEs. Functional analysis was not feasible as no cell lines are available. Table 1 summarises the variations found in the BBS8 gene during this study.
Conclusions
Mutations in BBS8 remain rare events in BBS family cohorts. BBS8 mutations were found in only 1% (3/259) of the families studied in an earlier publication, and in 2% (3/128) of the families examined in this study. The Pakistani family in Ansley's paper presented with a BBS phenotype associated with Situs Inversus; however, to our knowledge, none of the patients reported herein exhibited this feature. BBS7 and BBS8 have been found to participate in the same process at the level of ciliary intraflagellar transport (Blacque et al. 2004 ). Interestingly, only one patient in family one harboured a ''third mutated allele''; however, the BBS7 heterozygous mutation predicted to affect splicing is not present in affected siblings, casting doubt on its pathogenicity as no clinical differences between the siblings were noted. To date, BBS1 is the major BBS gene, accounting for at least 20% of BBS gene mutations found in affected families (Hichri et al. 2005) . About 50% of the BBS families in various studies do not carry mutations in known BBS genes, suggesting that other genes remain to be identified. Numerous genes are probably involved in this unique syndrome and traditional genotyping remains a difficult task, stressing the need for automated genotyping for heterogeneous conditions. 
